Organophosphate Flame Retardants, Obesity, and Depressive Symptoms among 1019 Young Healthy Men

Authors:

Abstract
Organophosphate flame retardants (OPFRs) can increase fat accumulation and exert neurotoxic effects. In this study, we enrolled 1019 young men who provided 3,550 urine samples over a 3-month follow-up period. We measured nine OPFR metabolite concentrations in urine samples and assessed depressive symptoms using the Beck Depression Inventory questionnaire. In the fully adjusted linear regression models, a 2.7-fold increase in urinary diphenyl phosphate (DPHP) concentrations was associated with a 0.44 unit (95% confidence interval (CI): 0.06, 0.82) higher depressive symptom scores. When men were categorized as having any depressive symptoms (score: > 10 vs ≤ 10), Poisson regression models showed an increased risk of depression across DPHP tertiles (P trend = 0.08). Further, we found stronger associations between urinary OPFR metabolite concentrations and depressive symptom scores among men with a higher waist circumference, waist-hip ratio, or waist-height ratio (P interaction < 0.15). The machine learning algorithm identified three different patterns of obesity, and the strongest association between urinary DPHP concentrations and depressive symptom scores was observed among men with a waist-hip ratio of ≥ 0.89 and a body mass index of 2. In summary, exposure to OPFRs may be associated with depressive symptoms among young men, especially in those with abdominal obesity.
Funding Information
  • National Natural Science Foundation of China (42477462, 82473581)

This publication has 103 references indexed in Scilit: